Preparation method and application of cordyceps sinensis extract

Through ethanol extraction, water extraction and alkali aqueous solution extraction combined with column chromatography technology, the water-soluble polysaccharides in Cordyceps sinensis were isolated, which solved the problem of insufficient activity of Cordyceps sinensis extract, achieved the effect of improving immune and anti-tumor activity, and reduced the Production cost.

CN118987056APending Publication Date: 2024-11-22DONGGUAN HEC CORDYCEPS R&D CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410609024.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-05-16
Filing Date
2024-05-16
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

In the prior art, there are few researches on the water-soluble polysaccharides of Cordyceps sinensis, which leads to insufficient activity of Cordyceps sinensis extracts, low resource utilization rate, high production cost, and difficulty in developing new products.

Method used

The water-insoluble polysaccharide in Cordyceps is isolated by using ethanol extraction, water extraction and alkali aqueous solution extraction combined with column chromatography. Through soaking, permeation, precipitation, centrifugation, washing and other steps, the water-insoluble polysaccharide in Cordyceps is isolated to improve its immune and anti-tumor activity.

Benefits of technology

The immune and anti-tumor activity of Cordyceps extract was significantly improved, especially in increasing TNF-α concentration and anti-colon cancer, improving resource utilization and reducing production costs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004843021180000161
    Figure BDA0004843021180000161
  • Figure HDA0004843021190000011
    Figure HDA0004843021190000011
  • Figure HDA0004843021190000012
    Figure HDA0004843021190000012
Patent Text Reader

Abstract

The invention provides a preparation method and application of a cordyceps sinensis extract, and belongs to the technical field of preparation of active extracts of traditional Chinese medicinal materials. The method comprises extraction and column chromatography, wherein the extraction comprises ethanol extraction, water extraction and aqueous alkali extraction. The cordyceps sinensis extract provided by the invention has good technical effects of improving immunity and / or resisting tumors, especially on improving the concentration of TNF-alpha and / or resisting colon cancer, and in addition, the preparation method of the cordyceps sinensis extract provided by the invention is beneficial to improving the utilization rate of cordyceps sinensis resources. The development of a new cordyceps sinensis product is facilitated, and the production cost of the cordyceps sinensis product is reduced in a manner of saving raw materials.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of preparation of active extracts of traditional Chinese medicines, and in particular to a preparation method of a cordyceps sinensis extract and application thereof. Background Art

[0002] Chinese Cordyceps is a complex of residual insect body, sclerotium and fungal stroma formed after the fungus Ophiocordyceps sinensis (Berk) infects and parasitizes the host bat moth larvae (Hepialidae). It is a traditional precious tonic medicinal material in my country. Cordyceps has a long history of medicinal use. According to research, the earliest citation was from the ancient Tibetan medicine book "Zang Materia Medica", which first recorded the function of Cordyceps sinensis to "tonify the kidney and moisten the lungs". Cordyceps sinensis has a variety of active substances, such as nucleosides, sterols, cordycepic acid, proteins, polysaccharides, etc., among which polysaccharides are one of the main contributors to the pharmacological activity of Cordyceps sinensis. Cordyceps sinensis polysaccharides mainly include intracellular and extracellular polysaccharides, accounting for 3-8% of the total mass of Cordyceps sinensis. Based on current research, it is known that the effects of polysaccharides in Cordyceps sinensis include anti-oxidation, anti-tumor, immune regulation, blood sugar regulation, etc.

[0003] However, there are few studies on Cordyceps sinensis extracts in the prior art. How to obtain Cordyceps sinensis extracts with better activity, improve the utilization rate of Cordyceps sinensis resources, develop new Cordyceps sinensis products, save raw materials, and reduce the production cost of Cordyceps sinensis products are the problems that researchers need to solve. Summary of the invention

[0004] In the prior art, although the active polysaccharides of Cordyceps sinensis have been widely studied, there is little research on water-insoluble polysaccharides. The present invention targets the water-insoluble polysaccharides in Cordyceps sinensis, further explores the substances with immune and anti-tumor activities in Cordyceps sinensis, and improves the utilization rate of Cordyceps sinensis resources. It is conducive to the development of new Cordyceps sinensis products and reduces the production cost of Cordyceps sinensis products by saving raw materials.

[0005] To achieve the above-mentioned purpose, the present invention provides a Cordyceps sinensis extract and a preparation method and application thereof.

[0006] In a first aspect, the present invention provides a Cordyceps sinensis extract.

[0007] A cordyceps sinensis extract, the preparation method of the cordyceps sinensis extract comprising: extraction and column chromatography.

[0008] In some embodiments, the extraction comprises: ethanol extraction, water extraction and alkaline aqueous solution extraction.

[0009] In some embodiments, the ethanol extraction comprises reflux extraction with ethanol solution 3.

[0010] In some embodiments, the water extraction comprises refluxing the Cordyceps sinensis powder with water after refluxing the ethanol solution 3.

[0011] In some embodiments, the alkaline aqueous solution extraction comprises drying the Cordyceps sinensis powder after water reflux extraction and then extracting it with an alkaline aqueous solution under an inert gas atmosphere.

[0012] In some embodiments, the preparation method further comprises soaking and percolation before the extracting.

[0013] In some embodiments, the soaking and percolation comprises soaking the Cordyceps sinensis powder with ethanol solution 1; and then percolating with ethanol solution 2.

[0014] In some embodiments, the preparation method further comprises performing a first post-treatment after the extraction.

[0015] In some embodiments, the first post-treatment includes filtration, neutralization and concentration, and washing.

[0016] In some embodiments, the column chromatography includes separation using an anion exchange chromatography column, and the Cordyceps sinensis extract is obtained through a second post-treatment.

[0017] In some embodiments, a Cordyceps sinensis extract is prepared by a method comprising:

[0018] (1) Soaking and percolating: soaking the Cordyceps sinensis powder in ethanol solution 1; then percolating with ethanol solution 2;

[0019] (2) Ethanol extraction: The percolation cordyceps powder was extracted by reflux with ethanol solution 3;

[0020] (3) Water extraction: After the ethanol solution 3 is refluxed and extracted, the Cordyceps sinensis powder is then refluxed and extracted with water;

[0021] (4) Alkaline aqueous solution extraction: The Cordyceps sinensis powder after water reflux extraction is dried and then extracted with alkaline aqueous solution under inert gas atmosphere;

[0022] (5) Filtration: Filter the Cordyceps sinensis powder after extraction with the alkaline aqueous solution and collect the filtrate;

[0023] (6) Neutralization and concentration: neutralize the filtrate with acid, collect the supernatant, and concentrate to obtain a concentrate;

[0024] (7) Precipitation and centrifugation: The concentrate was mixed with ethanol solution 4, allowed to stand for precipitation, centrifuged, and the precipitate was collected;

[0025] (8) washing: the precipitate is washed with anhydrous ethanol, acetone and ether in sequence to obtain cold alkali extract NCAP (cold alkali extract polysaccharide); and

[0026] (9) Column chromatography: The cold alkali extract NCAP is separated by an anion exchange chromatography column and subjected to a second post-treatment to obtain the Cordyceps sinensis extract.

[0027] In some embodiments, the ethanol solution 1 is a 90% vol-98% vol ethanol aqueous solution. In some embodiments, the ethanol solution 1 is a 93% vol-97% vol ethanol aqueous solution. In some embodiments, the ethanol solution 1 is a 90% vol, 91% vol, 92% vol, 93% vol, 94% vol, 95% vol, 96% vol, 97% vol or 98% vol ethanol aqueous solution. In some embodiments, the ethanol solution 1 is a 95% vol ethanol aqueous solution.

[0028] In some embodiments, the ethanol solution 2 is a 90% vol-98% vol ethanol aqueous solution. In some embodiments, the ethanol solution 2 is a 90% vol, 91% vol, 92% vol, 93% vol, 94% vol, 95% vol, 96% vol, 97% vol or 98% vol ethanol aqueous solution. In some embodiments, the ethanol solution 2 is a 95% vol ethanol aqueous solution.

[0029] In some embodiments, the ethanol solution 3 is an ethanol aqueous solution of 75% vol-85% vol. In some embodiments, the ethanol solution 3 is an ethanol aqueous solution of 78% vol-82% vol. In some embodiments, the ethanol solution 3 is an ethanol aqueous solution of 75% vol, 76% vol, 77% vol, 78% vol, 79% vol, 80% vol, 81% vol, 82% vol, 83% vol, 84% vol or 85% vol. In some embodiments, the ethanol solution 3 is an ethanol aqueous solution of 80% vol.

[0030] In some embodiments, the ethanol solution 4 is an ethanol aqueous solution of 90% vol-98% vol. In some embodiments, the ethanol solution 4 is an ethanol aqueous solution of 93% vol-97% vol. In some embodiments, the ethanol solution 4 is an ethanol aqueous solution of 90% vol, 91% vol, 92% vol, 93% vol, 94% vol, 95% vol, 96% vol, 97% vol or 98% vol. In some embodiments, the ethanol solution 4 is an ethanol aqueous solution of 95% vol.

[0031] In some embodiments, the base in the aqueous base solution comprises sodium hydroxide or potassium hydroxide.

[0032] In some embodiments, the concentration of the alkali in the aqueous alkali solution is 1wt%-5wt%. In some embodiments, the concentration of the alkali in the aqueous alkali solution is 1wt%, 2wt%, 3wt%, 4wt% or 5wt%. In some embodiments, the concentration of the alkali in the aqueous alkali solution is 3wt%.

[0033] In some embodiments, in the soaking step, 1g of the Cordyceps sinensis powder is soaked in 4ml-100ml of ethanol solution 1. In some embodiments, in the soaking step, 1g of the Cordyceps sinensis powder is soaked in 4ml, 5ml, 6ml, 7ml, 8ml, 9ml, 10ml, 15ml, 20ml, 30ml, 35ml, 40ml, 45ml, 50ml, 60ml, 70ml, 80ml, 90ml or 100ml of ethanol solution 1. In some embodiments, in the soaking step, 1g of the Cordyceps sinensis powder is soaked in 4ml-10ml of ethanol solution 1. Or 1g of the Cordyceps sinensis powder is soaked in 6ml of ethanol solution 1.

[0034] In some embodiments, in the percolation step, 10-100 ml of ethanol solution 2 is used for percolation per 1 g of the Cordyceps sinensis powder. In some embodiments, in the percolation step, 10 ml, 12 ml, 14 ml, 16 ml, 18 ml, 20 ml, 25 ml, 30 ml, 40 ml, 50 ml, 60 ml, 70 ml, 80 ml, 90 ml or 100 ml of ethanol solution 2 is used for percolation per 1 g of the Cordyceps sinensis powder. In some embodiments, in the percolation step, 14 ml of ethanol solution 2 is used for percolation per 1 g of the Cordyceps sinensis powder.

[0035] In some embodiments, in the ethanol extraction step, 5ml-100ml of ethanol solution 3 is used for reflux extraction per 1g of the Cordyceps powder. In some embodiments, in the ethanol extraction step, 5ml, 7ml, 8ml, 9ml, 10ml, 15ml, 20ml, 25ml, 30ml, 40ml, 50ml, 60ml, 70ml, 80ml, 90ml or 100ml of ethanol solution 3 is used for reflux extraction per 1g of the Cordyceps powder. In some embodiments, in the ethanol extraction step, 8ml of ethanol solution 3 is used for reflux extraction per 1g of the Cordyceps powder.

[0036] In some embodiments, in the water extraction step, 5ml-100ml of water is used for reflux extraction per 1g of the Cordyceps powder. In some embodiments, in the water extraction step, 5ml, 7ml, 8ml, 9ml, 10ml, 15ml, 20ml, 25ml, 30ml, 40ml, 50ml, 60ml, 70ml, 80ml, 90ml or 100ml of water is used for reflux extraction per 1g of the Cordyceps powder. In some embodiments, in the water extraction step, 10ml of water is used for reflux extraction per 1g of the Cordyceps powder.

[0037] In some embodiments, in the alkaline aqueous solution extraction step, 5ml-100ml of alkaline aqueous solution is used for extraction per 1g of the Cordyceps sinensis powder. In some embodiments, in the alkaline aqueous solution extraction step, 5ml, 7ml, 8ml, 9ml, 10ml, 15ml, 20ml, 25ml, 30ml, 40ml, 50ml, 60ml, 70ml, 80ml, 90ml or 100ml of alkaline aqueous solution is used for extraction per 1g of the Cordyceps sinensis powder. In some embodiments, in the alkaline aqueous solution extraction step, 10ml of alkaline aqueous solution is used for extraction per 1g of the Cordyceps sinensis powder.

[0038] In some embodiments, during the precipitation and centrifugation steps, the volume ratio of the concentrate to the ethanol solution 4 is 1:2-1:10. In some embodiments, during the precipitation and centrifugation steps, the volume ratio of the concentrate to the ethanol solution 4 is 1:2, 1:3, 1:4, 1:5, 1:6, 1:7, 1:8, 1:9 or 1:10. In some embodiments, during the precipitation and centrifugation steps, the volume ratio of the concentrate to the ethanol solution 4 is 1:4.

[0039] In some embodiments, the soaking temperature is 10° C.-35° C. In some embodiments, the soaking temperature is 15° C.-30° C. In some embodiments, the soaking temperature is 20° C.-25° C.

[0040] In some embodiments, the extraction temperature of the ethanol extraction is 75° C.-80° C. In some embodiments, the extraction temperature of the ethanol extraction is 75° C., 76° C., 77° C., 78° C., 79° C. or 80° C.

[0041] In some embodiments, the water extraction temperature is 90° C.-100° C. In some embodiments, the water extraction temperature is 90° C., 91° C., 92° C., 93° C., 94° C., 95° C., 96° C., 97° C., 98° C., 99° C., or 100° C. In some embodiments, the water extraction temperature is 95° C.

[0042] In some embodiments, the extraction temperature of the alkaline aqueous solution extraction is 5° C.-15° C. In some embodiments, the extraction temperature of the alkaline aqueous solution extraction is 5° C., 6° C., 7° C., 8° C., 9° C., 10° C., 11° C., 12° C., 13° C., 14° C. or 15° C. In some embodiments, the extraction temperature of the alkaline aqueous solution extraction is 10° C.

[0043] In some embodiments, the concentration is performed at 60° C.-70° C. In some embodiments, the concentration is performed at 60° C., 61° C., 62° C., 63° C., 64° C., 65° C., 66° C., 67° C., 68° C., 69° C., or 70° C. In some embodiments, the concentration is performed at 60° C.

[0044] In some embodiments, the precipitation is carried out at 2° C.-10° C. In some embodiments, the precipitation is carried out at 2° C., 3° ​​C., 4° C., 5° C., 6° C., 7° C., 8° C., 9° C. or 10° C. In some embodiments, the precipitation is carried out at 4° C.

[0045] In some embodiments, the post-treatment in the column chromatography includes: neutralization, concentration, dialysis desalination, and drying. In some embodiments, the neutralization in the second post-treatment is neutralized by 0.1mol / L-6.0mol / L hydrochloric acid aqueous solution. In some embodiments, the neutralization in the second post-treatment is neutralized by 0.2mol / L-6.0mol / L hydrochloric acid aqueous solution. In some embodiments, the neutralization in the second post-treatment is neutralized by 0.2mol / L-1.0mol / L hydrochloric acid aqueous solution. In some embodiments, the neutralization in the second post-treatment is neutralized by 0.1mol / L, 0.2mol / L, 0.3mol / L, 0.4mol / L, 0.5mol / L, 0.6mol / L, 0.7mol / L, 0.8mol / L, 0.9mol / L, 1.0mol / L, 1.5mol / L, 2.0mol / L, 3.0mol / L, 4.0mol / L, 5.0mol / L or 6.0mol / L hydrochloric acid aqueous solution.

[0046] In some embodiments, the drying is lyophilization.

[0047] In some embodiments, the soaking time is 8 hours to 20 hours. In some embodiments, the soaking time is 8 hours, 9 hours, 10 hours, 11 hours, 12 hours, 13 hours, 14 hours, 15 hours, 16 hours, 17 hours, 18 hours, 19 hours or 20 hours. In some embodiments, the soaking time is 12 hours.

[0048] In some embodiments, the extraction time of the ethanol extraction is 1 h to 8 h. In some embodiments, the extraction time of the ethanol extraction is 2 h to 4 h. In some embodiments, the extraction time of the ethanol extraction is 1 h, 2 h, 3 h, 4 h, 5 h, 6 h, 7 h or 8 h.

[0049] In some embodiments, the ethanol extraction comprises refluxing the ethanol solution 3 after the percolation of the Cordyceps sinensis powder, then replacing it with a new ethanol solution 3 and repeating the refluxing extraction 1-4 times. In some embodiments, the ethanol extraction comprises refluxing the ethanol solution 3 after the percolation of the Cordyceps sinensis powder, then replacing it with a new ethanol solution 3 and repeating the refluxing extraction 1, 2, 3 or 4 times.

[0050] In some embodiments, the water extraction time is 1-8 hours. In some embodiments, the water extraction time is 2 hours to 4 hours. In some embodiments, the water extraction time is 2 hours, 3 hours or 4 hours.

[0051] In some embodiments, the water extraction comprises refluxing the Cordyceps powder with water after the ethanol solution 3 is refluxed and then using new water to repeat the reflux extraction 1-7 times. In some embodiments, the water extraction comprises refluxing the Cordyceps powder with water after the ethanol solution 3 is refluxed and then using new water to repeat the reflux extraction 1, 2, 3, 4, 5, 6 or 7 times.

[0052] In some embodiments, the extraction time of the alkaline aqueous solution extraction is 12h-48h. In some embodiments, the extraction time of the alkaline aqueous solution extraction is 12h, 15h, 20h, 22h, 24h, 26h, 28h, 30h, 35h, 40h, 45h or 48h.

[0053] In some embodiments, the alkaline aqueous solution extraction comprises extracting the Cordyceps sinensis powder after the water reflux extraction with an alkaline aqueous solution, then replacing it with a new alkaline aqueous solution and then repeating the extraction 2-5 times. In some embodiments, the alkaline aqueous solution extraction comprises extracting the Cordyceps sinensis powder after the water reflux extraction with an alkaline aqueous solution, then replacing it with a new alkaline aqueous solution and then repeating the extraction 2, 3, 4 or 5 times.

[0054] In some embodiments, the neutralization in the first post-treatment is performed using an acid, and the acid includes at least one of hydrochloric acid or a hydrochloric acid aqueous solution, phosphoric acid or a phosphoric acid aqueous solution, formic acid or a formic acid aqueous solution.

[0055] In some embodiments, the acid in the neutralization in step (6) includes at least one of hydrochloric acid or an aqueous solution of hydrochloric acid, phosphoric acid or an aqueous solution of phosphoric acid, formic acid or an aqueous solution of formic acid.

[0056] In some embodiments, the concentration of hydrochloric acid in the aqueous hydrochloric acid solution is 1mol / L-10mol / L. In some embodiments, the concentration of hydrochloric acid in the aqueous hydrochloric acid solution is 1mol / L, 2mol / L, 3mol / L, 4mol / L, 5mol / L, 6mol / L, 7mol / L, 8mol / L, 9mol / L or 10mol / L. In some embodiments, the concentration of hydrochloric acid in the aqueous hydrochloric acid solution is 5mol / L-7mol / L. In some embodiments, the concentration of hydrochloric acid in the aqueous hydrochloric acid solution is 6mol / L.

[0057] In some embodiments, the inert gas includes at least one of nitrogen, helium, neon, argon, krypton, or xenon.

[0058] In some embodiments, the filler of the anion exchange chromatography column is DEAE-52.

[0059] In some embodiments, the inner diameter of the anion exchange chromatography column is 1 cm-3 cm; the length of the anion exchange chromatography column is 10 cm-50 cm. In some embodiments, the inner diameter of the anion exchange chromatography column is 1 cm, 2 cm, 2.6 cm or 3 cm; the length of the anion exchange chromatography column is 10 cm, 15 cm, 20 cm, 25 cm, 30 cm, 35 cm, 40 cm, 45 cm or 50 cm.

[0060] In some embodiments, the inner diameter of the anion exchange chromatography column is 1 cm, and the length of the anion exchange chromatography column is 10 cm.

[0061] In some embodiments, the inner diameter of the anion exchange chromatography column is 2.6 cm, and the length of the anion exchange chromatography column is 30 cm.

[0062] In some embodiments, the separation includes pre-treating the cold alkali extract NCAP to obtain a sample solution, then applying the sample solution to an anion exchange chromatography column for gradient elution, and collecting the eluate.

[0063] In some embodiments, the pretreatment includes: dissolving the cold alkali extract NCAP in an alkaline aqueous solution, heating to dissolve, cooling to room temperature, neutralizing with an acidic aqueous solution, dialyzing and desalting with water as the dialysis external fluid, then dialyzing with Tris-HCl buffer as the dialysis external fluid, collecting the dialysis internal fluid, centrifuging, taking the supernatant, and obtaining a sample solution.

[0064] In some embodiments, the alkaline aqueous solution is an aqueous sodium hydroxide solution.

[0065] In some embodiments, the concentration of the alkali in the alkaline aqueous solution is 0.2 mol / L-0.7 mol / L. In some embodiments, the concentration of the alkali in the alkaline aqueous solution is 0.2 mol / L, 0.3 mol / L, 0.4 mol / L, 0.5 mol / L, 0.6 mol / L or 0.7 mol / L. In some embodiments, the concentration of the alkali in the alkaline aqueous solution is 0.5 mol / L.

[0066] In some embodiments, the acidic aqueous solution is an aqueous hydrochloric acid solution.

[0067] In some embodiments, the concentration of the acid in the acidic aqueous solution is 0.2 mol / L-0.7 mol / L. In some embodiments, the concentration of the acid in the acidic aqueous solution is 0.2 mol / L, 0.3 mol / L, 0.4 mol / L, 0.5 mol / L, 0.6 mol / L or 0.7 mol / L. In some embodiments, the concentration of the acid in the acidic aqueous solution is 0.5 mol / L.

[0068] In some embodiments, the pH of the Tris-HCl buffer is 6.0-8.0. In some embodiments, the pH of the Tris-HCl buffer is 6.0, 6.5, 7.0, 7.5 or 8.0. In some embodiments, the pH of the Tris-HCl buffer is 7.0.

[0069] In some embodiments, the concentration of Tris-HCl in the Tris-HCl buffer is 0.01mol / L-0.50mol / L. In some embodiments, the concentration of Tris-HCl in the Tris-HCl buffer is 0.01mol / L, 0.02mol / L, 0.03mol / L, 0.04mol / L, 0.05mol / L, 0.10mol / L, 0.20mol / L, 0.30mol / L, 0.40mol / L or 0.50mol / L. In some embodiments, the concentration of Tris-HCl in the Tris-HCl buffer is 0.02mol / L.

[0070] In some embodiments, the molecular weight cutoff of the dialysis is 3.0 kDa-20.0 kDa. In some embodiments, the molecular weight cutoff of the dialysis is 3.0 kDa-10.0 kDa. In some embodiments, the molecular weight cutoff of the dialysis is 3.0 kDa-3.5 kDa. In some embodiments, the molecular weight cutoff of the dialysis is 3.5 kDa-5.0 kDa. The molecular weight cutoff of the dialysis is 3.0 kDa, 3.5 kDa, 4.0 kDa, 4.5 kDa, 5.0 kDa, 6.0 kDa, 7.0 kDa, 8.0 kDa, 9.0 kDa or 10.0 kDa.

[0071] In some embodiments, the mass ratio of the sample in the sample solution (calculated by the amount of cold alkali extract NCAP fed) to the filler of the anion exchange chromatography column in the separation step is 1:80-1:400. In some embodiments, the mass ratio of the sample in the sample solution (calculated by the amount of cold alkali extract NCAP fed) to the filler of the anion exchange chromatography column in the separation step is 1:80, 1:100, 1:150, 1:200, 1:250, 1:300, 1:350 or 1:400. In some preferred embodiments, the mass ratio of the sample in the sample solution (calculated by the amount of cold alkali extract NCAP fed) to the filler of the anion exchange chromatography column in the separation step is 1:80.

[0072] In some embodiments, the gradient elution is:

[0073] 0.01mol / L-0.50mol / L Tris-HCl buffer at pH 6.0-8.0 is used as buffer A, 0.3mol / L-3.0mol / L NaCl aqueous solution is used as buffer B, 0.1mol / L-2.0mol / L NaOH aqueous solution is used as buffer C, the flow rate is 0.5ml / min-8.0ml / min, and the elution process is as follows:

[0074] (1) Buffer A is used to elute 1.00-10.00 times the volume of the anion exchange column;

[0075] (2) 0%-50% buffer B and 100%-50% buffer A are uniformly eluted in a ratio of 1.00-10.00 times the volume of the anion exchange chromatography column;

[0076] (3) 50%-100% buffer B and 50%-0% buffer A are uniformly eluted in a ratio of 0.30-4.00 times the volume of the anion exchange chromatography column;

[0077] (4) 100% buffer B elution 1.00-10.00 times the volume of the anion exchange chromatography column;

[0078] (5) Buffer C elution: 1.60-16.00 times the volume of the anion exchange chromatography column.

[0079] In some embodiments, the concentration of Tris-HCl in buffer A is 0.01 mol / L-0.05 mol / L. In some embodiments, the concentration of Tris-HCl in buffer A is 0.01 mol / L, 0.02 mol / L, 0.03 mol / L, 0.04 mol / L or 0.05 mol / L.

[0080] In some embodiments, the concentration of NaCl in buffer B is 0.5mol / L-2mol / L. In some embodiments, the concentration of NaCl in buffer B is 0.8mol / L-1.5mol / L. In some embodiments, the concentration of NaCl in buffer B is 0.5mol / L, 0.6mol / L, 0.7mol / L, 0.8mol / L, 0.9mol / L, 1.0mol / L, 1.1mol / L, 1.2mol / L, 1.3mol / L, 1.4mol / L, 1.5mol / L or 2.0mol / L.

[0081] In some embodiments, the concentration of NaOH in buffer C is 0.1mol / L-1.0mol / L. In some embodiments, the concentration of NaOH in buffer C is 0.3mol / L-0.8mol / L. In some embodiments, the concentration of NaOH in buffer C is 0.1mol / L, 0.2mol / L, 0.3mol / L, 0.4mol / L, 0.5mol / L, 0.6mol / L, 0.7mol / L, 0.8mol / L, 0.9mol / L or 1.0mol / L.

[0082] In some embodiments, the pH of buffer A is 6.0, 6.5, 7.0, 7.5 or 8.0.

[0083] In some embodiments, the elution volume of buffer A in step (1) of the gradient elution is 1.00, 2.00, 3.00, 3.14, 4.00, 5.00, 6.00, 6.37, 7.00, 8.00, 9.00 or 10.00 times the volume of the anion exchange chromatography column.

[0084] In some embodiments, the elution volume of step (2) of the gradient elution is 1.00, 2.00, 3.00, 3.14, 4.00, 5.00, 6.00, 6.37, 7.00, 8.00, 9.00 or 10.00 times the volume of the anion exchange chromatography column.

[0085] In some embodiments, the elution volume of step (3) of the gradient elution is 0.30, 0.50, 0.80, 0.90, 1.00, 1.10, 1.20, 1.27, 1.30, 1.40, 1.50, 1.60, 1.70, 1.80, 1.90, 2.00, 2.50, 3.0, 3.50 or 4.00 times the volume of the anion exchange chromatography column.

[0086] In some embodiments, the elution volume of step (4) of the gradient elution is 1.00, 2.00, 3.00, 3.14, 4.00, 4.50, 5.00, 5.03, 5.50, 6.00, 6.37, 6.50, 7.00, 8.00, 9.00 or 10.00 times the volume of the anion exchange chromatography column.

[0087] In some embodiments, the elution volume of step (5) of the gradient elution is 1.60, 2.00, 3.00, 3.14, 4.00, 4.50, 5.00, 5.03, 5.50, 6.00, 6.37, 6.50, 7.00, 8.00, 9.00, 10.00, 11.00, 12.00, 13.00, 14.00, 15.00 or 16.00 times the volume of the anion exchange chromatography column.

[0088] In some embodiments, the flow rate is 0.5 ml / min, 0.6 ml / min, 0.7 ml / min, 0.8 ml / min, 0.9 ml / min, 1.0 ml / min, 1.1 ml / min, 1.2 ml / min, 1.5 ml / min, 2.0 ml / min, 2.5 ml / min, 3.0 ml / min, 3.5 ml / min, 4.0 ml / min, 4.5 ml / min, 5.0 ml / min, 5.5 ml / min, 6.0 ml / min, 6.5 ml / min, 6.8 ml / min, 6.9 ml / min, 7.0 ml / min, 7.2 ml / min, 7.5 ml / min or 8.0 ml / min.

[0089] In some embodiments, the gradient elution is:

[0090] 0.02 mol / L Tris-HCl buffer at pH 7.0 was used as buffer A, 1.0 mol / L NaCl aqueous solution was used as buffer B, 0.50 mol / L NaOH aqueous solution was used as buffer C, the flow rate was 1 ml / min, and the elution process was as follows:

[0091] (1) Buffer A is used to elute 1.00-10.00 times the volume of the anion exchange column;

[0092] (2) 0%-50% buffer B and 100%-50% buffer A are uniformly eluted in a ratio of 1.00-10.00 times the volume of the anion exchange chromatography column;

[0093] (3) 50%-100% buffer B and 50%-0% buffer A are uniformly eluted in a ratio of 0.30-4.00 times the volume of the anion exchange chromatography column;

[0094] (4) 100% buffer B elution 1.00-10.00 times the volume of the anion exchange chromatography column;

[0095] (5) Buffer C elution: 1.60-16.00 times the volume of the anion exchange chromatography column.

[0096] In some embodiments, a Cordyceps sinensis extract is prepared by a method comprising:

[0097] (1) soaking and percolation: soaking the cordyceps powder in a 95% vol ethanol aqueous solution for 8 to 20 hours; then percolating with the 95% vol ethanol aqueous solution; in the soaking step, 4 ml to 20 ml of the 95% vol ethanol aqueous solution is used for soaking per 1 g of the cordyceps powder; in the percolation step, 10 ml to 25 ml of the 95% vol ethanol aqueous solution is used for percolation per 1 g of the cordyceps powder;

[0098] (2) Ethanol extraction: The percolation cordyceps powder was reflux-extracted with an 80% vol ethanol aqueous solution; 5 ml to 20 ml of an 80% vol ethanol aqueous solution was used for reflux extraction per 1 g of the cordyceps powder; the percolation cordyceps powder was reflux-extracted with the ethanol solution for 3 times, and then reflux-extracted with 5 ml to 20 ml of a new 80% vol ethanol aqueous solution for 1 to 4 times;

[0099] (3) Water extraction: The Cordyceps sinensis powder extracted with 80% vol ethanol aqueous solution is then extracted with water; 5 ml to 20 ml of water is used for reflux extraction per 1 g of the Cordyceps sinensis powder; the Cordyceps sinensis powder extracted with 80% vol ethanol aqueous solution is then extracted with water, followed by reflux extraction with 5 ml to 20 ml of new water, and then the reflux extraction is repeated 4 to 7 times;

[0100] (4) Alkaline aqueous solution extraction: The Cordyceps sinensis powder after water reflux extraction is then extracted with a 3 wt % NaOH aqueous solution under an inert gas atmosphere; 5 ml to 20 ml of a 3 wt % NaOH aqueous solution is used for extraction per 1 g of the Cordyceps sinensis powder; the Cordyceps sinensis powder after water reflux extraction is extracted with an alkaline aqueous solution and then replaced with 5 ml to 20 ml of a new 3 wt % NaOH aqueous solution and the extraction is repeated 2 to 5 times;

[0101] (5) Filtration: Filter the Cordyceps sinensis powder after extraction with the alkaline aqueous solution and collect the filtrate;

[0102] (6) Neutralization and concentration: neutralize the filtrate with aqueous hydrochloric acid, collect the supernatant, and concentrate to obtain a concentrate;

[0103] (7) Precipitation and centrifugation: The concentrate was mixed with 95% vol ethanol aqueous solution, allowed to stand for precipitation, centrifuged, and the precipitate was collected;

[0104] (8) washing: the precipitate is washed with anhydrous ethanol, acetone and ether in sequence to obtain a cold alkali extract NCAP; and

[0105] (9) Column chromatography: pre-treating the cold alkali extract NCAP to obtain a sample solution, then applying the sample solution to an anion exchange chromatography column for gradient elution, collecting the eluate, preferably collecting the eluate of buffer C, and performing a second post-treatment to obtain the Cordyceps sinensis extract;

[0106] The filler of the anion exchange chromatography column is DEAE-52; the gradient elution is:

[0107] 0.02 mol / L Tris-HCl buffer at pH 7.0 is used as buffer A, 1.0 mol / L NaCl aqueous solution is used as buffer B, 0.50 mol / L NaOH aqueous solution is used as buffer C, the flow rate is 0.5 ml / min-8.0 ml / min, and the elution process is as follows:

[0108] (1) Buffer A is used to elute 1.00-10.00 times the volume of the anion exchange column;

[0109] (2) 0%-50% buffer B and 100%-50% buffer A are uniformly eluted in a ratio of 1.00-10.00 times the volume of the anion exchange chromatography column;

[0110] (3) 50%-100% buffer B and 50%-0% buffer A are uniformly eluted in a ratio of 0.30-4.00 times the volume of the anion exchange chromatography column;

[0111] (4) 100% buffer B elution 1.00-10.00 times the volume of the anion exchange chromatography column;

[0112] (5) Buffer C elution: 1.00-1.60 times the volume of the anion exchange column.

[0113] In some embodiments, the flow rate is 1.0 ml / min x (inner diameter of anion exchange chromatography column ÷ 1 cm) 2 , the unit of the inner diameter of the anion exchange chromatography column is cm or converted to cm.

[0114] In some embodiments, the column chromatography operation, before gradient elution, also includes column packing and balancing: the DEAE-52 filler is pretreated according to conventional operations, and then soaked in 1.0 mol / L NaCl aqueous solution and then wet packed; after column packing, the chromatography column is equilibrated with buffer A.

[0115] In some embodiments, the conventional operation includes: soaking the DEAE-52 filler in water, filtering to remove water, then soaking it in an acid aqueous solution (such as a hydrochloric acid aqueous solution), then washing it with water until the pH is neutral, filtering to remove water, then soaking it in an alkaline aqueous solution (such as a sodium hydroxide aqueous solution), and then washing it with water until the pH is neutral. In some embodiments, the conventional operation includes: soaking the DEAE-52 filler in water for 1h-4h, filtering to remove water, then soaking it in a 0.2mol / L-1.0mol / L hydrochloric acid aqueous solution for 1h-4h, then washing it with water until the pH is neutral, filtering to remove water, then soaking it in a 0.2mol / L-1.0mol / L sodium hydroxide aqueous solution for 1h-4h, and then washing it with water until the pH is neutral. In some embodiments, the conventional operation includes: soaking the DEAE-52 filler in water for 2h, filtering to remove water, then soaking it in a 0.5mol / L hydrochloric acid aqueous solution for 2h, then washing it with water until the pH is neutral, filtering to remove water, then soaking it in a 0.5mol / L sodium hydroxide aqueous solution for 2h, and then washing it with water until the pH is neutral.

[0116] In a second aspect, the present invention provides a preparation method.

[0117] A method for preparing a Cordyceps sinensis extract, characterized by comprising the preparation method described in the first aspect. In a third aspect, the present invention provides an application of the Cordyceps sinensis extract described in the first aspect or the Cordyceps sinensis extract obtained by the preparation method described in the second aspect.

[0118] A use of the Cordyceps sinensis extract of the first aspect or the Cordyceps sinensis extract obtained by the preparation method of the second aspect in the preparation of a product for improving immunity and / or anti-tumor.

[0119] In some embodiments, a Cordyceps sinensis extract described in the first aspect or a Cordyceps sinensis extract obtained by the preparation method described in the second aspect is used in the preparation of a product for increasing TNF-α (tumor necrosis factor-α) concentration and / or anti-colon cancer.

[0120] In some embodiments, the product for improving immunity and / or anti-tumor is a pharmaceutical product.

[0121] In some embodiments, the immunity-enhancing product is a health product.

[0122] Beneficial Effects

[0123] Compared with the prior art, the present invention has the following beneficial effects:

[0124] The cordyceps extract provided by the present invention has good technical effects of improving immunity and / or anti-tumor, especially in improving TNF-α concentration and / or anti-colon cancer, and is much higher in immunity and / or anti-tumor activity than the extracts in the cold alkali extract NCAP and other eluents of the elution procedure (for example, it has better activity of improving TNF-α concentration and / or higher anti-colon cancer activity), and has unexpected excellent technical effects. In addition, the preparation method of the cordyceps extract provided by the present invention is conducive to improving the utilization rate of cordyceps resources. It is conducive to the development of new cordyceps products and reduces the production cost of cordyceps products by saving raw materials.

[0125] Terminology

[0126] In the description of the present invention, “plurality” means two or more than two, unless otherwise clearly and specifically defined.

[0127] The term "room temperature" means ambient temperature, referring to a temperature between about 10°C and about 30°C, or between about 20°C and 30°C, or about 25°C.

[0128] In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "example", "specific example", or "some examples" etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine the different embodiments or examples described in this specification and the features of the different embodiments or examples, without contradiction.

[0129] The term "v / v" means volume ratio.

[0130] The term "% vol" means volume percentage.

[0131] The term "wt%" means percent by mass.

[0132] The term "kDa" means kilodaltons, a unit of weight average molecular weight. The term "Da" means Daltons, a unit of weight average molecular weight.

[0133] The term "kGy" stands for kilogray, which is the abbreviation of kilogray. It is a unit of absorbed dose and a physical unit used to measure the "energy absorbed dose" (absorbed dose for short) caused by ionizing radiation. It describes the amount of ionizing radiation energy absorbed by an object per unit mass.

[0134] The "neutralization" mentioned in the present invention refers to adjusting the pH to 6.5-7.5.

[0135] DEAE-52 filler refers to DEAE-Cellulose filler, that is, diethylaminoethyl cellulose filler, and its CAS number is 9013-34-7.

[0136] In the following, all numbers disclosed herein are approximate, regardless of whether the word "about" or "approximately" is used. The value of each number may vary by 1%, 2%, 5%, 7%, 8%, 10%, 15% or 20%. Whenever a number with a value of N is disclosed, any number with a value of N+ / -1%, N+ / -2%, N+ / -3%, N+ / -5%, N+ / -7%, N+ / -8%, N+ / -10%, N+ / -15% or N+ / -20% will be explicitly disclosed, where "+ / -" means plus or minus. BRIEF DESCRIPTION OF THE DRAWINGS

[0137] Figure 1 This is the result of polysaccharide-protein staining in Example 3; Lane 1 is the Coomassie Brilliant Blue staining picture; Lane 2 is the Schiff staining picture.

[0138] Figure 2 These are UV scanning spectra of the CPP sample before and after treatment in Example 4.

[0139] Figure 3 This is a standard curve diagram for the analysis of total sugar content in Example 5.

[0140] Figure 4 The figure is a statistical graph of the activity effects of different groups in inducing RAW264.7 cells to secrete NO in Example 8, wherein Ctrl is the negative control group; LPS is the lipopolysaccharide treatment group (1 μg / mL); CPP is the experimental group; a represents a comparison with the negative control group, p<0.05; d represents a comparison with the negative control group, p<0.0001.

[0141] Figure 5 This is a statistical diagram of the in vitro inhibitory activity results of CPP and CPP-macrophage conditioned medium on HT-29 cells in Example 9;

[0142] Among them, b means compared with the negative control group, p<0.01; d means compared with the control group, p<0001. DETAILED DESCRIPTION

[0143] In order to enable those skilled in the art to better understand the technical solution of the present invention, some non-limiting embodiments are further disclosed below to further describe the present invention in detail.

[0144] The reagents used in the present invention can be purchased from the market or prepared by the method described in the present invention.

[0145] The "solid-to-liquid ratio" mentioned in the present application refers to the ratio of the mass of Cordyceps sinensis powder to the volume of solvent. For example, a solid-to-liquid ratio of 1:6 (w / v, g / mL) means that every 1 g of Cordyceps sinensis powder is mixed with 6 mL of solvent.

[0146] Instruments and Materials

[0147] Source of medicinal materials: Cordyceps sinensis breeding products (Guangdong East Sunshine Pharmaceutical Co., Ltd., batch number No. 0414).

[0148] ELISA kit (Invivogen), sodium hydroxide (Runjie Chemical Reagent Co., Ltd. (Shanghai)), sodium chloride (Shanghai Runjie Chemical Reagent Co., Ltd.), Tris-HCl (Roche Diagnostics Products (Shanghai) Co., Ltd.), DEAE-52 (purchased from Sinopharm Chemical Reagent Co., Ltd., Sinopharm code: 68005281), dialysis bag (Rebus (Shanghai)), fetal bovine serum (PAA Laboratories), 10,000U penicillin / 10mg / mL streptomycin (Sigma Aldrich), Dulbecco's Modified Eagle Medium (Invitrogen Thermo Fisher Scientific), RPMI 1640 powder (Sigma Aldrich), HT-29 cells (Cell Bank of the Chinese Academy of Sciences), human THP-1 cell line (Cell Bank of the Chinese Academy of Sciences), lipopolysaccharide (Sigma Aldrich), phorbol esters (Sigma Aldrich), Human TNF alpha Uncoated ELISA Kit (Invitrogen Thermo Fisher Scientific), ethanol (Shanghai Runjie Chemical Reagent Co., Ltd.), and hydrochloric acid (Jiangsu Qiangsheng Functional Chemical Co., Ltd.).

[0149] CT15RT high-speed refrigerated centrifuge (Tianmei Scientific Instrument Co., Ltd. (Shanghai)), XS205 electronic analytical balance (METTLER TOLEDO), DK-S24 electric constant temperature water bath (Jinghong Experimental Equipment Co., Ltd. (Shanghai)), UV-2450 ultraviolet-visible spectrophotometer (Shimadzu, Japan), AFZ-1002-U ultrapure water meter (Aicopu International Co., Ltd.), Model 680 microplate reader (BIO RAD), HF151 cell culture incubator (Heal Force), BX41 inverted microscope (OLYMPUS), MRF-B clean bench (Steag), TH-3560 high pressure sterilizer (Vertical Sterilizer TSAO HSIN), HPLC workstation (BECKMANGOLD 125), GZX-9146 electric constant temperature blast drying oven (Shanghai Boxun Industry), LPY-24 shaker (Shanghai Centrifugal Machinery Research Institute).

[0150] Example 1: Preparation of Cordyceps sinensis extract

[0151] Weigh 50g of Cordyceps sinensis powder and add 95%vol ethanol aqueous solution according to the material-liquid ratio of 1:6 (w / v, g / mL) (material-liquid ratio of 1:6 (w / v, g / mL) means that 1g of solid material is added with 6mL of solvent, and the meaning of other material-liquid ratios in this application document is analogous), and soak at room temperature for 12h; add 95%vol ethanol aqueous solution according to the material-liquid ratio of 1:14 (w / v, g / mL) for percolation; add 80%vol ethanol aqueous solution to the Cordyceps sinensis powder after percolation according to the material-liquid ratio of 1:8 (w / v, g / mL) and reflux extract at 80℃ for 2h, then replace with new 80%vol ethanol aqueous solution according to the material-liquid ratio of 1:8 (w / v, g / mL) and repeat the reflux extraction at 80℃ for 2h once, for a total of 2 times, to obtain Cordyceps sinensis powder extracted with 80%vol ethanol aqueous solution.

[0152] After the Cordyceps sinensis powder was extracted with 80% vol ethanol aqueous solution, water was added at a solid-liquid ratio of 1:10 (w / v, g / mL), and reflux extraction was performed at 95°C for 2 hours. The extraction was repeated 4 times with new water at a solid-liquid ratio of 1:10 (w / v, g / mL), for a total of 5 times, to obtain the water-extracted Cordyceps sinensis powder.

[0153] The Cordyceps powder after water extraction was dried in an oven at 50°C and weighed, and a 3wt% NaOH aqueous solution was added at a solid-liquid ratio of 1:10 (w / v, g / mL), and stirred and extracted at 10°C for 24h under nitrogen protection. A new 3wt% NaOH aqueous solution was used at a solid-liquid ratio of 1:10 (w / v, g / mL) and the step of "stirring and extracting at 10°C for 24h under nitrogen protection" was repeated twice, for a total of 3 times. Then, the extract was filtered to obtain the extract, and the solid (named CAER) was collected.

[0154] Take the filtered extract, add 6mol / L HCl aqueous solution dropwise to neutralize, collect the supernatant, and concentrate at 60°C to obtain a concentrated solution. Add 4 times the volume of 95% vol ethanol aqueous solution to the concentrated solution, precipitate at 4°C for 12 hours, then centrifuge at 10000 rpm for 5 minutes, and collect the precipitate. The precipitate is washed with anhydrous ethanol, acetone and ether (all with a concentration of 100%) in turn to obtain the cold alkali extract NCAP.

[0155] DEAE-52 anion exchange chromatography was used to separate the NCAP components of the alkali extract. The specifications of the chromatography column were an inner diameter (d1) of 1 cm and a length (L1) of 10 cm. The separation steps were as follows:

[0156] Sample treatment: Mix cold alkali extract NCAP with 0.5mol / L NaOH aqueous solution. Mix 1g cold alkali extract NCAP with 100mL0.5mol / L NaOH aqueous solution, protect with nitrogen, heat at 95℃ for 5min, and after complete dissolution, let it cool to room temperature, and add 0.50mol / L HCl aqueous solution to neutralize. Use distilled water as the dialysis external liquid for dialysis desalination (molecular weight cutoff is 3.5kDa), and check with AgNO3. Before loading, use 0.02mol / L Tris-HCl (pH7.0) as the dialysis external liquid for dialysis. After the dialysis is completed, collect the dialysis internal liquid and centrifuge it at 6000rpm for 20min, take the supernatant, and obtain the sample solution.

[0157] Column packing and equilibration: After soaking the DEAE-52 filler in purified water for 2 hours, filter out the water, add 0.5mol / L HCl solution to the filler and soak it for 2 hours, then wash it with purified water until neutral; after filtering out the water, add 0.5mol / L sodium hydroxide aqueous solution and soak it for 2 hours, then wash it with purified water until neutral. Soak the treated filler in 1.0mol / L NaCl aqueous solution and wet pack it in the column (d×L, 1×10cm). After column packing, replace the mobile phase with buffer A (0.02mol / L Tris-HCl buffer (pH 7.0)) to equilibrate the chromatographic column.

[0158] Loading: Apply the sample solution to a DEAE-52 chromatography column at a ratio of 1:80 (the mass of the sample (calculated based on the cold alkali extract NCAP feed amount) to the mass of the filler in the sample solution, g / g) for gradient elution.

[0159] Gradient elution: Buffer A (0.02 mol / L Tris-HCl buffer (pH 7.0)), buffer B (1.0 mol / L NaCl aqueous solution), buffer C (0.50 mol / L NaOH aqueous solution) were used for elution at a flow rate of 1 mL / min. The elution process is as follows:

[0160] (1) 50 mL of buffer A (approximately 6.37 column volumes)

[0161] (2) 0%-50% buffer B and 100%-50% buffer A were uniformly varied in proportion to elute 30 mL (approximately 3.82 column volumes);

[0162] (3) 50%-100% buffer B and 50%-0% buffer A were uniformly eluted in a ratio of 10 mL (about 1.27 column volumes);

[0163] (4) 100% buffer B elution 20 mL (about 2.55 column volumes);

[0164] (5) 50 mL of buffer C (approximately 6.37 column volumes);

[0165] During the elution process, the change in absorbance at 230 nm was detected, and 3 mL of the eluate was collected in a tube. The elution position of the target substance was determined by the change in the response value.

[0166] When eluted with buffer C, the phenol-sulfuric acid method test results showed a polysaccharide absorption peak and an absorption peak at 230 nm, indicating that the component contained protein components. The buffer C eluates were combined, neutralized with HCl (0.1 mol / L-6.0 mol / L hydrochloric acid aqueous solution can be used for neutralization), concentrated, dialyzed for desalination (molecular weight cutoff is 3.5 kDa), and freeze-dried to obtain a sample named CPP.

[0167] Example 2: Scale-up preparation

[0168] The sample solution obtained in Example 1 (the sample solution can also be prepared by linear amplification based on the preparation method described in Example 1) was separated by DEAE-52 anion exchange chromatography. The specifications of the chromatography column were an inner diameter (d2) of 2.6 cm and a length (L2) of 30 cm. The sample was loaded and separated at a ratio of 1:80 between the mass of the sample (calculated based on the amount of cold alkali extract NCAP fed) and the mass of the filler in the sample solution. The separation steps were as follows:

[0169] According to the "Preparative Chromatography Technology and Application", the separated components in NCAP were prepared and the flow rate was linearly amplified. The preparation conditions are as follows: Preparative column flow rate = analytical column flow rate × (d2 / d1) 2 =6.76ml / min;

[0170] The analytical column in the above formula is the chromatography column described in Example 1;

[0171] Buffer A (0.02 mol / L Tris-HCl buffer (pH 7.0)), buffer B (1.0 mol / L NaCl aqueous solution), and buffer C (0.50 mol / L NaOH aqueous solution) were used for elution at a flow rate of 6.76 mL / min.

[0172] Elution was performed according to the following elution program:

[0173] (1) 500 mL of buffer A (approximately 3.14 column volumes);

[0174] (2) 0%-50% buffer B and 100%-50% buffer A were uniformly varied in proportion to elute 500 mL (approximately 3.14 column volumes);

[0175] (3) 50%-100% buffer B and 50%-0% buffer A were uniformly eluted in a ratio of 160 mL (approximately 1.00 column volume);

[0176] (4) 100% buffer B elution 500 mL (about 3.14 column volumes);

[0177] (5) 800 mL of buffer C (approximately 5.03 column volumes) was used for elution.

[0178] When eluted with buffer C, the phenol-sulfuric acid method showed a polysaccharide absorption peak and an absorption peak at 230 nm, indicating that the fraction contained protein components. The buffer C eluate was combined, neutralized with HCl (0.1 mol / L-6.0 mol / L hydrochloric acid aqueous solution can be used for neutralization), concentrated, dialyzed for desalination (molecular weight cutoff is 3.5 kDa), and freeze-dried. The obtained sample was named CPP.

[0179] Example 3: SDS-1% agarose gel-transfer electrophoresis analysis

[0180] Sample treatment: Weigh 4 mg of CPP sample and dissolve it in 1× loading buffer (solid protein loading buffer) to prepare a loading stock solution containing 4 mg / mL CPP sample, boil it in boiling water for 10 minutes, cool it to room temperature, centrifuge it at 12000 rpm for 5 minutes, take the supernatant, and obtain the sample solution.

[0181] Electrophoresis: Add the sample solution (20 μL / well) to a 1.5 cm SDS-1% agarose gel. Perform concentrated gel electrophoresis at a constant voltage of 120 V for 40 min; when the sample enters the separation gel, adjust the voltage to 150 V. End the electrophoresis when the indicator is 2 cm from the bottom edge of the gel.

[0182] Polysaccharide-protein staining: After cutting the sample strip at the target protein position for membrane transfer, cut it in the middle parallel to the sample strip, and stain the strip with Coomassie Brilliant Blue (protein stain) and Schiff reagent (polysaccharide stain) respectively.

[0183] The staining results show: Figure 1 As shown, there is only one protein band and one polysaccharide band, and the two bands appear at the same position, indicating that the polysaccharide and protein in the sample CPP are connected to each other to form a complex.

[0184] Example 4: Polysaccharide-peptide bond analysis

[0185] Alkali treatment sample solution: CPP sample was dissolved in 0.5mol / L NaOH aqueous solution and then NaBH4 aqueous solution was added to make the final concentration of CPP in the solution 5.0mg / mL, the final concentration of NaOH was 0.2mol / L, and the final concentration of NaBH4 was 1mol / L; after incubation at 45℃ for 30min, centrifuged at 2000rpm for 5min, and the supernatant was taken as the alkaline treatment sample solution. Blank control: A mixed solution with a final concentration of 0.2mol / LNaOH and 1.0mol / L NaBH4.

[0186] Sample solution without alkali treatment: CPP sample was first dissolved in 0.5 mol / L NaOH aqueous solution, then immediately neutralized with HCl solution, and NaBH4 aqueous solution was added to make the final concentration of CPP in the solution 5.0 mg / mL and the final concentration of NaBH4 was 1 mol / L; after incubation at 45°C for 30 min, centrifuged at 2000 rpm for 5 min, and the supernatant was taken as the sample solution without alkali treatment.

[0187] The alkali-treated sample solution and the non-alkali-treated sample solution were scanned from 230-260 nm on a UV-visible spectrophotometer. After deducting the blank, the scanning spectra of the alkali-treated sample solution and the non-alkali-treated sample solution were compared. The results are shown in Figure 2 .

[0188] By comparing the UV scanning spectra of the sample solution after alkali treatment and the sample solution without alkali treatment, it was found that the sample solution after alkali treatment had obvious absorbance at 240nm, indicating that an amination reaction occurred, suggesting that there was an O-glycosidic bond connection between the protein and the polysaccharide compound.

[0189] Example 5: Analysis of total sugar content

[0190] Sample treatment: Dry the sample CPP under reduced pressure in a P2O5 dryer, dissolve 2.5 mg of the sample in 0.5 mol / L NaOH solution (since the sample CPP is insoluble in distilled water, it needs to be dissolved in alkaline aqueous solution first), then neutralize with 0.5 mol / L HCl solution, add water to make the volume 25 mL, take 1 mL of the sample in a test tube, and obtain the sample group solution.

[0191] Preparation of standard curve: Accurately weigh about 10 mg of anhydrous glucose, dissolve it in water and make up to a 100 mL volumetric flask, respectively pipette 0, 0.1 mL, 0.2 mL, 0.3 mL, 0.4 mL, 0.5 mL, and 0.6 mL of glucose standard solution into test tubes, and make up to 1.0 mL with distilled water, vortex mix, and obtain standard curve group solutions of different concentrations.

[0192] Add 0.6 mL of 5% phenol solution to each tube of the sample group solution and the standard curve group solution, vortex; add 3.6 mL of concentrated sulfuric acid, vortex to mix. All concentrations were prepared twice in parallel, cooled to room temperature, and the absorbance was measured at 484 nm.

[0193] Results: The standard curve is as follows: Figure 3 As shown, the total polysaccharide content in CPP was calculated to be 44.42±0.04%.

[0194] Example 6: Protein determination in CPP

[0195] Determination of protein content in CPP by Coomassie Brilliant Blue method

[0196] Sample treatment: The dissolution method was the same as the "Sample treatment" step in Example 5, and CPP was prepared into a working solution containing 1 mg / mL CPP.

[0197] Preparation of standard curve: Using a solution containing NaOH and HCl of the same concentration as the working solution as the solvent, the standard BSA (2.0 mg / mL) was diluted to 1000 μg / mL, 750 μg / mL, 500 μg / mL, 250 μg / mL, and 0 μg / mL in sequence to obtain standard solutions of different concentrations.

[0198] Pipette 10 μL of CPP working solution and standard solutions of different concentrations respectively, add 500 μL of Coomassie Brilliant Blue dye solution respectively, vortex to mix, let stand for 2 minutes, transfer the reaction solution to the ELISA plate, and read the OD value of each well at 595 nm.

[0199] Linear regression equation: OD = 0.00118C (C: concentration, μg / mL), R 2 =0.998. The protein content in CPP was calculated based on the standard curve to be 23.53±1.36%.

[0200] Example 7: Determination of proteins in CPP by Nano-LC-Q-Orbitrap MS mass spectrometry

[0201] CPP was subjected to SDS-1% agarose gel electrophoresis. The electrophoresis was stopped when the sample strip reached 1 / 3 of the separation gel. The gel strip was cut and the protein and protein-specific polypeptide sequences contained therein were detected by nano-liquid chromatography (Nano-LC)-quadrupole orbital trap mass spectrometry (Q-Orbitrap MS). The CPP protein identification and analysis database Ophiocordyceps sinensis, and the data analysis software was PEAKS Studio X 10.0.

[0202] By comparing with the Ophiocordyceps sinensis database, three main protein components were detected in CPP, namely: T5ACM3, Linoleate 8R-lipoxygenase, and T5A562. Among them, proteins T5ACM3 and T5A562 have not been reported yet.

[0203] T5ACM3 accounted for 23.79% of the total protein in CPP and contained 4 unique peptides. The peptide (R.ADERLEFSR.G) was an unidentified peptide sequence in Ophiocordyceps sinensis and accounted for the highest proportion in this protein.

[0204] Linoleate 8R-lipoxygenase accounted for 15.52% of the total protein in CPP and contained 14 unique peptides.

[0205] T5A562 accounted for 9.75% of the total protein of CPP and had 2 unique peptides, as shown in Table 1 .

[0206] Table 1 Main protein and unique peptide sequences in CPP

[0207]

[0208] Example 8: CPP immunoreactivity assay

[0209] Cell recovery and culture:

[0210] Preparation of complete culture medium cRPMI 1640: Add FBS with a final concentration of 10% vol, double antibody (final concentration of 100 IU / mL penicillin and 100 μg / mL streptomycin) and 2-mercaptoethanol (final concentration of 0.05 mmol / L) to RPMI1640 culture medium and place in a 4°C refrigerator for use.

[0211] Culture: THP-1 cells were cultured in complete culture medium cRPMI 1640 in an atmosphere containing 5% CO2 and 95% air, saturated water vapor, and a constant temperature cell culture incubator at 37°C. The complete culture medium cRPMI 1640 was replaced every 3 days.

[0212] Sample treatment: Weigh 5 mg of CPP sample that has been vacuum dried overnight, sterilize by irradiation at 8 kGy, prepare a 5 mg / mL stock solution with sterile 1×PBS, heat at 60°C, and vortex continuously to form a suspension to obtain the CPP sample stock solution.

[0213] Determination of nitric oxide (NO) concentration by Griess method

[0214] Cell seeding plate: After cell enzymatic hydrolysis, blow evenly and adjust the cell density to 2.3×10 5 cell / mL, 100 μL per well was seeded in a 96-well plate and incubated in a constant temperature cell culture incubator for 24 h.

[0215] Sample addition: discard the culture medium, add 1×PBS to rinse (100μL / well), and after aspirating, add the corresponding sample solution or DMEM complete medium to each well. Negative control group: DMEM complete medium, 100μL per well; Positive control group: dilute LPS with DMEM complete medium to a final LPS concentration of 1μg / mL, 100μL per well; Experimental group: dilute CPP sample stock solution with DMEM complete medium to a final CPP concentration of 200μg / mL and 500μg / mL, respectively, 100μL per well. Each group was measured in parallel 3 times. After adding samples, move to the cell culture incubator and incubate for 24h.

[0216] Griess method for detecting NO secretion:

[0217] Standard curve: Take NaNO2 solution (100 μmol / mL) and dilute it with distilled water to make NaNO2 solutions with concentrations of 100 μmol / mL, 50 μmol / mL, 25 μmol / mL, and 12.5 μmol / mL. Take 50 μL of each concentration into a 96-well plate and measure each concentration in parallel 3 times.

[0218] After the incubation, 50 μL of culture medium was transferred from each well to a 96-well plate, and an equal volume of Greiss reagent (solution A: 1% sulfonamide, 2.5% phosphoric acid solution; solution B: 0.1% N-naphthyldiethylamine, solution A and solution B were mixed 1:1 before use) and mixed evenly. The plate was placed at room temperature and away from light for 20 minutes, and the OD value (optical density) of each well was measured at 550 nm using an ELISA reader, and the concentration of NO in the negative control group, positive control group, and experimental group was calculated. The results are shown in Figure 2. Figure 4 shown.

[0219] The results showed that the concentration of NO in the cell supernatant of the experimental groups with a final concentration of CPP samples of 200 μg / ml and 500 μg / ml was 0.6 times and 2.0 times that of the negative control group, respectively, indicating that CPP has a strong stimulating effect on RAW264.7.

[0220] TNF-α content determination

[0221] Phorbol ester (PMA) induced THP-1 to form macrophage subtypes: After THP-1 cells were counted, they were centrifuged at 1700 rpm for 5 min, the supernatant was discarded, and the THP-1 cell density was adjusted to 2.0×10 with culture medium (containing 100 ng / mL PMA). 5 After 500 μL / well was inoculated into a 24-well plate, the plate was incubated in a constant temperature cell culture incubator for 48 h.

[0222] Sample addition: After the THP-1 cells incubated with PMA adhere to the wall, the supernatant was discarded and the corresponding sample solution or cRPMI 1640 medium was added to each well. Negative control group: cRPMI 1640 medium, 500μL per well; positive control group: LPS was diluted with cRPMI 1640 medium to a final concentration of 1μg / mL, 500μL per well; experimental group: CPP sample mother solution was diluted with DMEM complete medium to a final concentration of 50μg / mL and 200μg / mL, respectively, 500μL per well. Each group was measured twice in parallel. After the addition of samples, the cells were moved to a cell culture incubator and incubated for 24h.

[0223] Sample collection: After the incubation, collect the supernatant in a 96-well plate at 150 μL / well and store in a -80°C refrigerator.

[0224] TNF-α content determination: The determination steps were carried out according to the instructions of the Invivogen ELISA kit, as follows:

[0225] ① Add 100 μL of 1×Coating buffer containing 1×Cap.Ab to the ELISA plate, seal it, and place it in a 4°C refrigerator overnight; shake off the solution in the plate, add 250 μL of wash buffer (sterile 1×PBS containing 0.05% Tween-20) to each well, soak on a shaker for 1 min, and pat off the solution in the plate on paper as much as possible. After washing 3 times, shake off the solution in the wells;

[0226] ② Block and incubate with 200 μL / well of 1×ELISA / ELISPOT at room temperature for 1 hour, shake off the solution in the wells; wash once or more with wash buffer, shake on a shaker for 1 minute each time, and pat off as much solution in each well as possible on paper;

[0227] ③ Sample addition: add 100 μL of sample to each well (the samples were diluted to the appropriate concentration in each group after preliminary experiments), seal, and incubate at room temperature for 2 hours;

[0228] Preparation of standard curve solution: Take new freeze-dried powder standard TNF-α and add 1mL DI Water (sterile deionized water), let it stand for 30 minutes, vortex to dissolve it, and get 500pg / mL standard sample, then dilute it with diluent to 250pg / mL, 125pg / mL, 62.5pg / mL, 31.25pg / mL, 15.63pg / mL, 7.81pg / mL. Add 100μL to each well and incubate for 120min at room temperature (protect from light);

[0229] ④After incubation, wash the plate 5 times with wash buffer, and each time, immerse it on a shaker for 1 minute, and wipe off the solution in the plate as much as possible on paper;

[0230] ⑤ Add 100 μL 1× Detection Antibody to each well, seal and incubate for 1 hour in a dark place;

[0231] ⑥ Wash at least 5 times with wash buffer, soak on a shaker for 1 minute each time, and wipe off as much solution as possible on paper;

[0232] ⑦ Add 100 μL streptavidin-HRP (1×) to each well, seal and incubate at room temperature in the dark for 30 min;

[0233] ⑧Wash at least 5-7 times with wash buffer, soak on a shaker for 1 minute each time, and tap off as much solution as possible on paper; add 100 μL 1× TMB to each well, seal and incubate at room temperature for 15 minutes in the dark;

[0234] ⑨Add 100 μL stop solution (1 mol / L H3PO4) to each well;

[0235] ⑩ Read the OD value with an enzyme-labeled instrument at 450nm.

[0236] result:

[0237] When the CPP concentration was 50 μg / mL and 200 μg / mL, the concentration of TNF-α in the cell supernatant of the CPP group was 3.1 and 8.3 times that of the negative control group, respectively, indicating that CPP has obvious immune activity.

[0238] Example 9: Determination of the inhibitory activity of CPP on human colorectal cancer cells

[0239] Cell recovery and culture:

[0240] Sample processing: Weigh 5 mg of CPP sample that has been vacuum dried overnight, sterilize it by irradiation at 8 kGy, prepare it into a 5 mg / mL stock solution with sterile 1× PBS, heat it at 60°C, and vortex it continuously to form a suspension to obtain the CPP sample stock solution.

[0241] cRPMI 1640 complete medium: the same as cRPMI 1640 complete medium in Example 8.

[0242] THP-1 cell culture: THP-1 cells were placed in complete culture medium cRPMI 1640 and cultured in a constant temperature cell culture incubator containing 5% CO2, 95% air, saturated water vapor, and 37°C. The complete culture medium cRPMI 1640 was replaced once every 3 days.

[0243] THP-1 plate: After the enzymatic hydrolysis, add cRPMI 1640 complete medium to terminate the enzymatic hydrolysis reaction, blow the cells evenly, and count them. Centrifuge at 300g for 5min, discard the supernatant, add medium, and adjust the cell density to 2×10 5 After 500 μl / well was added, the cells were seeded in a 24-well plate and incubated in a constant temperature cell culture incubator for 48 h.

[0244] HT-29 cell culture: HT-29 cells were placed in complete culture medium cRPMI 1640 and cultured in a constant temperature cell culture incubator containing 5% CO2, 95% air, and saturated water vapor at 37°C. The complete culture medium cRPMI 1640 was replaced once every 3 days.

[0245] HT-29 plate: After the enzymatic hydrolysis, add cRPMI 1640 complete medium to terminate the enzymatic hydrolysis reaction, blow the cells evenly, and count them. Centrifuge at 300g for 5 minutes, discard the supernatant, add medium, and adjust the cell density to 2×10 5 cells / mL, 100 μL / well, seeded in 96-well plates, and cultured in a cell culture incubator for 24 h.

[0246] Preparation of THP-1 conditioned medium (TCM) stimulated by CPP: Take the 24-well plate obtained after the THP-1 seed plate, discard the medium, and add the corresponding sample solution or cRPMI 1640 complete medium to each well. (1) Supernatant of TCM negative control group: Add cRPMI 1640 complete medium, 500 μL / well, incubate in a cell culture incubator for 48 hours, collect the supernatant and store it at -80℃ to obtain the supernatant of TCM negative control group; (2) Supernatant of TCM experimental group: Take the CPP sample mother solution and dilute it with cRPMI 1640 complete medium to a final CPP concentration of 50 μg / mL, 100 μg / mL, and 200 μg / mL, 500 μL / well; incubate in a cell culture incubator for 48 hours, collect the supernatant and store it at -80℃ to obtain supernatants of TCM experimental group with different concentrations, and measure each group in parallel 3 times.

[0247] MTT cell experiment experimental group, positive control group and negative control group grouping and sample addition: take the 96-well plate obtained after the HT-29 plate, discard the culture medium, and add the corresponding sample solution or cRPMI 1640 complete culture medium to each well. (1) TCM negative control group: add supernatant of TCM negative control group, 100 μL / well; (2) TCM experimental group: add supernatant of TCM experimental group with different concentrations (50 μg / mL, 100 μg / mL, 200 μg / mL), 100 μL / well; (3) CPP fresh medium group (fresh medium group, FCM experimental group): add CPP sample mother solution and dilute it with cRPMI 1640 complete medium to the final concentration of CPP of 50 μg / mL, 100 μg / mL, 200 μg / mL, 100 μL / well; (4) FCM negative control group: add cRPMI 1640 complete medium, 100 μL / well; (5) Positive control group: take 5-fluorouracil (5-Fu) and dilute it with cRPMI1640 complete medium to the final concentration of 5-fluorouracil of 50 μmol / mL, 100 μL / well. Each group was incubated for 48 h, and each group was measured six times in parallel.

[0248] MTT cell experiment blank group and sample addition: (1) TCM blank group: take a 96-well plate without cell seed plate, add different concentrations (50μg / mL, 100μg / mL, 200μg / mL) of TCM experimental group supernatant, 100μL / well, and incubate for 48h; (2) TCM negative control blank group: take a 96-well plate without cell seed plate, add TCM negative group supernatant, 100μL / well, and incubate for 48h; (3) FCM blank group: take a 96-well plate without cell seed plate, add different concentrations (50μg / mL, 100μg / mL, 200μg / mL) of CPP solution, 100μL / well, and incubate for 48h; (4) FCM negative control blank group: take a 96-well plate without cell seed plate, add cRPMI 1640 complete medium, 100μL / well, and incubate for 48h.

[0249] MTT assay:

[0250] 4 hours before the end of the 48-hour incubation experiment, add 10 μL of MTT (5 mg / mL) to each well and culture in a cell culture incubator for 4 hours. Add 0.1 mL of a triple dissolution solution (containing 10% SDS, 5% isobutanol, and 0.012 mol / L HCL in water) to each well and continue incubating in a cell culture incubator for 16 to 24 hours. Take the 96-well plate out of the cell culture incubator, put it at room temperature, and measure the OD value of each well at 570 nm with 650 nm as the reference.

[0251] The inhibition rate was calculated as:

[0252] Inhibition rate % = [1-(As-Ab1) / (Ac-Ab2)] × 100%

[0253] As: absorbance value of the experimental group (TCM experimental group or FCM experimental group) or the positive control group (cells + MTT + sample)

[0254] Ac: absorbance value of negative control group (TCM negative control group or FCM negative control group) (cells + MTT + culture medium)

[0255] Ab1: absorbance value of blank group (TCM blank group or FCM blank group) (MTT + sample)

[0256] Ab2: absorbance value of negative control blank group (TCM negative control blank group or FCM negative control blank group) (MTT+ culture medium / TCM negative group supernatant)

[0257] Experimental results:

[0258] MTT method was used to detect HT-29 cells: the ability and method of CPP to kill tumor cells were studied by comparing the inhibition rate of CPP and the conditioned medium after CPP stimulation of THP-1 on HT-29 cells.

[0259] The experiment was divided into FCM experimental group and TCM experimental group. According to the MTT test results, in the FCM experimental group, after CPP (50μg / mL, 100μg / mL, 200μg / mL) acted on HT-29 cells for 48h, the inhibition rates of HT-29 cells in different concentrations of FCM experimental groups were 0.86% (50μg / mL CPP concentration FCM experimental group), 2.16% (100μg / mL CPP concentration FCM experimental group), and 1.72% (200μg / mL CPP concentration FCM experimental group), respectively. Compared with the FCM negative control group, the inhibition was not concentration-dependent. In the TCM experimental group, the conditioned medium obtained after stimulating THP-1 with CPP (50μg / mL, 100μg / mL, 200μg / mL) solution stimulated HT-29 cells for 48h. The inhibition rate of HT-29 cells in each TCM experimental group increased with the increase of CPP concentration, which was 0% (TCM experimental group with 50μg / mL CPP concentration), 2.62% (TCM experimental group with 100μg / mL CPP concentration), and 6.8% (TCM experimental group with 200μg / mL CPP concentration), respectively. It was concentration-dependent and showed significant differences at 200μg / mL (p<0.01). At a concentration of 200μg / mL, the inhibition rates of HT-29 in the FCM experimental group and the TCM experimental group were as follows: Figure 5As shown, the inhibition rate of the positive control group (5-Fu group, 50 μmol / mL) was 23.7%.

[0260] From the above, it can be seen that CPP has a weak inhibitory effect on human colorectal cancer HT29 cells in vitro; however, the macrophage conditioned medium induced by CPP has a significant inhibitory effect on human colorectal cancer HT-29 cells.

[0261] The above results show that CPP can enhance immune response by regulating macrophage regulatory activity and stimulating the production of TNF-α inflammatory factors, and has an inhibitory effect on human colon cancer cells. Although chemical drugs have high efficacy, their toxic side effects are relatively obvious. CPP achieves anti-tumor effects by enhancing its own immunity and has higher safety. Therefore, CPP has good development potential in the application of immune regulation, tumor treatment or adjuvant treatment, and health products.

[0262] Comparative Example 1

[0263] Sample extraction

[0264] Alkaline water extraction: the CAER in Example 1 was added with a 3wt% NaOH aqueous solution at a solid-liquid ratio of 1:10 (w / v, g / mL), and stirred and extracted at 75°C under a nitrogen flow for 6 hours. After cooling to room temperature, the mixture was centrifuged at 7500rpm for 5 minutes to collect the precipitate. The precipitate was then replaced with a new 3wt% NaOH aqueous solution at a solid-liquid ratio of 1:10 (w / v, g / mL) and the operation of "stirring and extracting at 75°C under a nitrogen flow for 6 hours, cooling to room temperature, centrifuging at 7500rpm for 5 minutes, and collecting the precipitate" was repeated twice. The alkaline water extraction was performed three times in total to obtain a precipitate after three alkaline water extractions.

[0265] Water extraction: After the precipitate was extracted with alkaline water for three times, it was cooled and resuspended in 450 mL of water. The pH was adjusted to 7.0 with 1 mol / L HCl aqueous solution, and then centrifuged at 7500 rpm for 5 min. The supernatant was discarded, and the precipitate was washed with a large amount of water several times to remove the salt therein, and the solid after the hot alkali soluble components were removed was obtained. The solid after the hot alkali soluble components were removed was added with water at a solid-liquid ratio of 1:10 (w:v, g / mL), the pH was pre-adjusted to 3.0 with HCl, and then extracted at 80°C for 2 h. After the extraction, the extract was centrifuged at 7500 rpm for 5 min, and the precipitate was collected. Then the precipitate was replaced with new water at a solid-liquid ratio of 1:10 (w / v, g / mL), and the pH was pre-adjusted to 3.0 with HCl. Repeat "then extract at 80°C for 2 h, after the extraction, the extract was centrifuged at 7500 rpm for 5 min, and the precipitate was collected" once, and the water extraction was performed twice in total to obtain the precipitate after the water extraction twice;

[0266] Post-treatment: After the precipitate was extracted with water twice, it was cooled, resuspended in 450 mL of distilled water and the pH was adjusted to 7.0 with NaOH solution, then centrifuged at 7500 rpm for 5 min, the supernatant was discarded, and the precipitate after centrifugation was obtained. The precipitate after centrifugation was washed with a large amount of distilled water until there was no chloride ion reaction with AgNO3, and finally dried at 50°C to obtain the solids after removing the acid-soluble components, which were named CEP.

[0267] Total sugar content determination

[0268] The sample CEP (since the sample is insoluble in water and low concentrations of acid and alkali, it needs to be hydrolyzed with concentrated hydrochloric acid) was ground into powder until it passed through a 42-mesh sieve (355 μm). About 50 mg of sample powder was accurately weighed into a test tube, and 0.75 mL of concentrated hydrochloric acid was added. The mixture was placed in a 30°C water bath for 45 min (mixed every 15 min), and 5 mL of distilled water was added. The mixture was placed in a 100°C water bath for 2 h. After cooling, 5 mL of 2 mol / L KOH was added to each tube, and all the contents in the tube were quantitatively transferred to a 50 mL volumetric flask. The mixture was fixed to volume with 200 mM sodium acetate buffer, filtered with quantitative filter paper, and the filtrate was collected. 500 μL of the filtrate and 500 μL of distilled water were accurately measured and mixed. Then 100 μL of the above mixed solution was accurately measured, added with water to 1 mL, and mixed.

[0269] The determination method was the same as in Example 5. The total sugar content of CEP was determined to be 75.29±1.33%.

[0270] TNF-α content determination

[0271] Take a sample of CEP and measure the TNF-α content according to the method for measuring the TNF-α content in Example 8.

[0272] The results showed that at 50 μg / mL and 200 μg / mL, the concentration of TNF-α in the cell supernatant of the CEP group was 1.7 and 1.8 times that of the negative control group, respectively, and was significantly weaker than that of the CPP extract (3.1 and 8.3 times).

[0273] The method of the present invention has been described through preferred embodiments, and relevant personnel can obviously modify or appropriately change and combine the methods and applications described herein within the content, spirit and scope of the present invention to implement and apply the technology of the present invention. Those skilled in the art can refer to the content of this article and appropriately improve the process parameters. It is particularly important to point out that all similar replacements and modifications are obvious to those skilled in the art, and they are all considered to be included in the present invention.

Claims

1. A Cordyceps sinensis extract, characterized in that: The preparation method of the cordyceps sinensis extract comprises: soaking and percolation, extraction and column chromatography; the extraction comprises: ethanol extraction, water extraction and alkaline aqueous solution extraction; the column chromatography comprises separation using an anion exchange chromatography column, and a second post-treatment to obtain the cordyceps sinensis extract; Optionally, the ethanol extraction comprises reflux extraction with ethanol solution 3; Optionally, the water extraction comprises refluxing the Cordyceps sinensis powder extracted with the ethanol solution 3 and then refluxing it with water; Optionally, the alkaline aqueous solution extraction comprises drying the Cordyceps sinensis powder after water reflux extraction and then extracting it with an alkaline aqueous solution under an inert gas atmosphere; Optionally, the soaking and percolation comprises soaking the Cordyceps sinensis powder with ethanol solution 1; and then percolating with ethanol solution 2; Optionally, the preparation method further comprises performing a first post-treatment after the extraction; Optionally, the first post-treatment includes: filtration, neutralization, concentration and washing.

2. The Cordyceps sinensis extract according to claim 1, wherein the preparation method comprises: (1) Soaking and percolating: Soak the Cordyceps sinensis powder in ethanol solution 1; Then percolate with ethanol solution 2; (2) Ethanol extraction: The percolation cordyceps powder was extracted by reflux with ethanol solution 3; (3) Water extraction: After the ethanol solution 3 is refluxed and extracted, the Cordyceps sinensis powder is then refluxed and extracted with water; (4) Alkaline aqueous solution extraction: The Cordyceps sinensis powder after water reflux extraction is dried and then extracted with alkaline aqueous solution under inert gas atmosphere; (5) Filtration: Filter the Cordyceps sinensis powder after extraction with the alkaline aqueous solution and collect the filtrate; (6) Neutralization and concentration: neutralize the filtrate with acid, collect the supernatant, and concentrate to obtain a concentrate; (7) Precipitation and centrifugation: The concentrate was mixed with ethanol solution 4, allowed to stand for precipitation, centrifuged, and the precipitate was collected; (8) Washing: The precipitate is washed with anhydrous ethanol, acetone and ether in sequence to obtain the cold alkali extract NCAP; and (9) Column chromatography: The cold alkali extract NCAP is separated by an anion exchange chromatography column and subjected to a second post-treatment to obtain the Cordyceps sinensis extract.

3. The Cordyceps sinensis extract according to any one of claims 1 to 2, wherein the ethanol solution 1 is a 90% vol-98% vol ethanol aqueous solution or a 95% vol ethanol aqueous solution; and / or The ethanol solution 2 is a 90% vol-98% vol ethanol aqueous solution or a 95% vol ethanol aqueous solution; and / or The ethanol solution 3 is a 75% vol-85% vol ethanol aqueous solution or an 80% vol ethanol aqueous solution; and / or The ethanol solution 4 is a 90% vol-98% vol ethanol aqueous solution or a 95% vol ethanol aqueous solution; and / or The alkali in the aqueous alkali solution comprises sodium hydroxide or potassium hydroxide; and / or The concentration of the alkali in the aqueous alkali solution is 1 wt%-5 wt% or 3 wt%.

4. The Cordyceps sinensis extract according to any one of claims 1 to 3, wherein in the soaking step, 4 ml to 100 ml of ethanol solution 1 is used for soaking per 1 g of the Cordyceps sinensis powder, or 6 ml of ethanol solution 1 is used for soaking per 1 g of the Cordyceps sinensis powder; and / or In the percolation step, 10 ml to 100 ml of the ethanol solution 2 is used for percolation per 1 g of the cordyceps powder, or 14 ml of the ethanol solution 2 is used for percolation per 1 g of the cordyceps powder; and / or In the ethanol extraction step, 5 ml to 100 ml of the ethanol solution 3 is used for reflux extraction per 1 g of the Cordyceps sinensis powder, or 8 ml of the ethanol solution 3 is used for reflux extraction per 1 g of the Cordyceps sinensis powder; and / or In the water extraction step, 5ml-100ml of water is used for reflux extraction per 1g of the Cordyceps sinensis powder, or 10ml of water is used for reflux extraction per 1g of the Cordyceps sinensis powder; and / or In the alkaline aqueous solution extraction step, 5ml-100ml of alkaline aqueous solution is used for extraction per 1g of the Cordyceps sinensis powder, or 10ml of alkaline aqueous solution is used for extraction per 1g of the Cordyceps sinensis powder; and / or In the precipitation and centrifugation steps, the volume ratio of the concentrate to the ethanol solution 4 is 1:2-1:10 or 1:

4.

5. The Cordyceps sinensis extract according to any one of claims 1 to 4, wherein the soaking temperature is 10°C to 35°C; and / or The extraction temperature of the ethanol extraction is 75°C-80°C; and / or The water extraction temperature is 90-100°C or 95°C; and / or The extraction temperature of the alkaline aqueous solution extraction is 5-15°C, or the extraction temperature of the alkaline aqueous solution extraction is 10°C; and / or The concentration is carried out at 60°C-70°C, or at 60°C; and / or The precipitation is carried out at 2°C-10°C, or at 4°C; and / or The second post-treatment in the column chromatography comprises: Neutralization, concentration, desalting by dialysis, and drying.

6. The Cordyceps sinensis extract according to any one of claims 1 to 5, wherein the soaking time is 8 hours to 20 hours; and / or The extraction time of the ethanol extraction is 1h-8h or 2h-4h; and / or The ethanol extraction comprises the following steps: extracting the Cordyceps sinensis powder after percolation with the ethanol solution 3 under reflux, then replacing it with a new ethanol solution 3 and repeating the reflux extraction 1-4 times; and / or The water extraction time is 1-8h or 2h-4h; and / or The water extraction comprises the following steps: extracting the Cordyceps sinensis powder with water after the ethanol solution 3 is refluxed, replacing it with new water and then repeating the reflux extraction 1-7 times; and / or The extraction time of the alkaline aqueous solution extraction is 12h-48h; and / or The alkaline aqueous solution extraction comprises extracting the Cordyceps sinensis powder after the water reflux extraction with an alkaline aqueous solution and then replacing it with a new alkaline aqueous solution and repeating the extraction 2-5 times; and / or The acid in the neutralization comprises at least one of hydrochloric acid or a hydrochloric acid aqueous solution, phosphoric acid or a phosphoric acid aqueous solution, formic acid or a formic acid aqueous solution; and / or The concentration of hydrochloric acid in the hydrochloric acid aqueous solution is 1 mol / L-10 mol / L or 6 mol / L; and / or The inert gas includes at least one of nitrogen, helium, neon, argon, krypton or xenon.

7. The Cordyceps sinensis extract according to any one of claims 1 to 6, wherein the filler of the anion exchange chromatography column is DEAE-52; and / or The inner diameter of the anion exchange chromatography column is 1-3 cm; the length of the anion exchange chromatography column is 10-50 cm; or The inner diameter of the anion exchange chromatography column is 1 cm, and the length of the anion exchange chromatography column is 10 cm; or The inner diameter of the anion exchange chromatography column is 2.6 cm, and the length of the anion exchange chromatography column is 30 cm; and / or The separation comprises pre-treating the cold alkali extract NCAP to obtain a sample solution, then applying the sample solution to an anion exchange chromatography column for gradient elution, and collecting the eluate; and / or The pre-processing comprises: Dissolve the cold alkali extract NCAP in an alkaline aqueous solution, heat to dissolve, cool to room temperature, neutralize with an acidic aqueous solution, dialyze to remove salt using water as a dialysate external solution, then dialyze with Tris-HCl buffer as a dialysate external solution, collect the dialysate internal solution, centrifuge, and take the supernatant to obtain a sample solution; and / or The alkaline aqueous solution is a sodium hydroxide aqueous solution; and / or The concentration of the alkali in the alkaline aqueous solution is 0.2 mol / L-0.7 mol / L or 0.5 mol / L; and / or The acidic aqueous solution is a hydrochloric acid aqueous solution; and / or The acid concentration in the acidic aqueous solution is 0.2 mol / L-0.7 mol / L or 0.5 mol / L; and / or The pH of the Tris-HCl buffer is 6.0-8.0 or 7.0; and / or The concentration of Tris-HCl in the Tris-HCl buffer is 0.01 mol / L-0.50 mol / L or 0.02 mol / L; and / or The molecular weight cut-off of the dialysis is 3.0 kDa-20.0 kDa; and / or In the separation step, the mass ratio of the sample in the sample solution to the filler of the anion exchange chromatography column is 1:80-1:400, preferably 1:

80.

8. The Cordyceps sinensis extract according to claim 7, wherein the gradient elution is: 0.01mol / L-0.50mol / L Tris-HCl buffer at pH 6.0-8.0 is used as buffer A, 0.3mol / L-3.0mol / L NaCl aqueous solution is used as buffer B, 0.1mol / L-2.0mol / L NaOH aqueous solution is used as buffer C, and the flow rate is 0.5ml / min-8.0ml / min or the flow rate is 1.0ml / min×(inner diameter of anion exchange chromatography column÷1cm) 2 , the inner diameter of the anion exchange chromatography column is in cm or converted to cm, and the elution process is as follows: (1) Buffer A is used to elute 1.00-10.00 times the volume of the anion exchange column; (2) 0%-50% buffer B and 100%-50% buffer A are uniformly eluted in a ratio of 1.00-10.00 times the volume of the anion exchange chromatography column; (3) 50%-100% buffer B and 50%-0% buffer A are uniformly eluted in a ratio of 0.30-4.00 times the volume of the anion exchange chromatography column; (4) 100% buffer B is eluted in a volume of 1.00-10.00 times the volume of the anion exchange chromatography column; (5) 1.60-16.00 times the volume of the anion exchange column for elution with buffer C; or The gradient elution is: 0.02 mol / L Tris-HCl buffer at pH 7.0 was used as buffer A, 1.0 mol / L NaCl aqueous solution was used as buffer B, 0.50 mol / L NaOH aqueous solution was used as buffer C, the flow rate was 1 ml / min, and the elution process was as follows: (1) Buffer A is used to elute 1.00-10.00 times the volume of the anion exchange column; (2) 0%-50% buffer B and 100%-50% buffer A are uniformly eluted in a ratio of 1.00-10.00 times the volume of the anion exchange chromatography column; (3) 50%-100% buffer B and 50%-0% buffer A are uniformly eluted in a ratio of 0.30-4.00 times the volume of the anion exchange chromatography column; (4) 100% buffer B is eluted in a volume of 1.00-10.00 times the volume of the anion exchange chromatography column; (5) Buffer C elution: 1.60-16.00 times the volume of the anion exchange chromatography column.

9. The Cordyceps sinensis extract according to any one of claims 1 to 8, characterized in that The preparation method comprises: (1) soaking and percolation: soaking the cordyceps powder in a 95% vol ethanol aqueous solution for 8 to 20 hours; then percolating with the 95% vol ethanol aqueous solution; in the soaking step, 4 ml to 20 ml of the 95% vol ethanol aqueous solution is used for soaking per 1 g of the cordyceps powder; in the percolation step, 10 ml to 25 ml of the 95% vol ethanol aqueous solution is used for percolation per 1 g of the cordyceps powder; (2) Ethanol extraction: The percolation cordyceps powder was reflux-extracted with an 80% vol ethanol aqueous solution; 5 ml to 20 ml of an 80% vol ethanol aqueous solution was used for reflux extraction per 1 g of the cordyceps powder; the percolation cordyceps powder was reflux-extracted with the ethanol solution for 3 times, and then reflux-extracted with 5 ml to 20 ml of a new 80% vol ethanol aqueous solution for 1 to 4 times; (3) Water extraction: The Cordyceps sinensis powder extracted with 80% vol ethanol aqueous solution is then extracted with water; 5 ml to 20 ml of water is used for reflux extraction per 1 g of the Cordyceps sinensis powder; the Cordyceps sinensis powder extracted with 80% vol ethanol aqueous solution is then extracted with water, followed by reflux extraction with 5 ml to 20 ml of new water, and then the reflux extraction is repeated 4 to 7 times; (4) Alkaline aqueous solution extraction: The Cordyceps sinensis powder after water reflux extraction is then extracted with a 3 wt % NaOH aqueous solution under an inert gas atmosphere; 5 ml to 20 ml of a 3 wt % NaOH aqueous solution is used for extraction per 1 g of the Cordyceps sinensis powder; the Cordyceps sinensis powder after water reflux extraction is extracted with an alkaline aqueous solution and then replaced with 5 ml to 20 ml of a new 3 wt % NaOH aqueous solution and the extraction is repeated 2 to 5 times; (5) Filtration: Filter the Cordyceps sinensis powder after extraction with the alkaline aqueous solution and collect the filtrate; (6) Neutralization and concentration: neutralize the filtrate with aqueous hydrochloric acid, collect the supernatant, and concentrate to obtain a concentrate; (7) Precipitation and centrifugation: The concentrate was mixed with 95% vol ethanol aqueous solution, allowed to stand for precipitation, centrifuged, and the precipitate was collected; (8) washing: the precipitate is washed with anhydrous ethanol, acetone and ether in sequence to obtain a cold alkali extract NCAP; and (9) Column chromatography: pre-treating the cold alkali extract NCAP to obtain a sample solution, then applying the sample solution to an anion exchange chromatography column for gradient elution, collecting the eluate, preferably collecting the eluate of buffer C, and performing a second post-treatment to obtain the Cordyceps sinensis extract; The filler of the anion exchange chromatography column is DEAE-52; the gradient elution is: 0.02 mol / L Tris-HCl buffer at pH 7.0 is used as buffer A, 1.0 mol / L NaCl aqueous solution is used as buffer B, 0.50 mol / L NaOH aqueous solution is used as buffer C, and the flow rate is 0.5 ml / min-8.0 ml / min or the flow rate is 1.0 ml / min×(inner diameter of anion exchange chromatography column ÷ 1 cm) 2 , wherein the inner diameter of the anion exchange chromatography column is in cm or converted to cm; and the elution process is as follows: (1) eluting with buffer A at 1.00-10.00 times the volume of the anion exchange chromatography column; (2) 0%-50% buffer B and 100%-50% buffer A are uniformly eluted in a ratio of 1.00-10.00 times the volume of the anion exchange chromatography column; (3) 50%-100% buffer B and 50%-0% buffer A are uniformly eluted in a ratio of 0.30-4.00 times the volume of the anion exchange chromatography column; (4) 100% buffer B elution 1.00-10.00 times the volume of the anion exchange chromatography column; (5) Buffer C elution: 1.00-1.60 times the volume of the anion exchange column.

10. A method for preparing a Cordyceps sinensis extract, characterized in that: The invention comprises the preparation method according to any one of claims 1 to 9.

11. Use of the Cordyceps sinensis extract according to any one of claims 1 to 9 or the Cordyceps sinensis extract prepared by the preparation method according to claim 10 in preparing a product for improving immunity and / or anti-tumor; or use of the Cordyceps sinensis extract according to any one of claims 1 to 9 or the Cordyceps sinensis extract prepared by the preparation method according to claim 10 in preparing a product for increasing TNF-α concentration and / or anti-colon cancer.